Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![PavanPav17997 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1808282427875643392.png) pavan kandgal [@PavanPav17997](/creator/twitter/PavanPav17997) on x XX followers
Created: 2025-07-25 23:18:54 UTC

Rev: ₹1,932 Cr (↓7.4% YoY) → softness due to base effect & price pressure.

Albuterol: #1 rank in US MDI inhaler mkt (19.5% share).

Launched Nano Paclitaxel (ANDA) & Nilotinib (NDA).

Signed 1st US biosimilar launch — gAdvair nearing, gSymbicort in FY27

#stockmarketcrash


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948885702038749319/c:line.svg)

[Post Link](https://x.com/PavanPav17997/status/1948885702038749319)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

PavanPav17997 Avatar pavan kandgal @PavanPav17997 on x XX followers Created: 2025-07-25 23:18:54 UTC

Rev: ₹1,932 Cr (↓7.4% YoY) → softness due to base effect & price pressure.

Albuterol: #1 rank in US MDI inhaler mkt (19.5% share).

Launched Nano Paclitaxel (ANDA) & Nilotinib (NDA).

Signed 1st US biosimilar launch — gAdvair nearing, gSymbicort in FY27

#stockmarketcrash

XX engagements

Engagements Line Chart

Post Link

post/tweet::1948885702038749319
/post/tweet::1948885702038749319